Novel diagnostic method for breast cancer and ovarian cancer
About 5-10 % of all breast cancers are hereditary, and in 30-40% of these cases a mutation in the BRCA1/2 genes can be detected. The tumor biology of carcinomas with BRCA1 mutation differs significantly from sporadic cancers and cases with BRCA2 mutations involved. It is known that in breast cancer tissue shows a significantly higher T3 receptor (Trijodothyronin receptor, THR) binding capacity as compared to normal breast tissue.
Further Information: PDF
Bayerische Patentallianz GmbH
Phone: +49 89 5480177-0
Contact
Peer Biskup
Media Contact
All latest news from the category: Technology Offerings
Newest articles
Why getting in touch with our ‘gerbil brain’ could help machines listen better
Macquarie University researchers have debunked a 75-year-old theory about how humans determine where sounds are coming from, and it could unlock the secret to creating a next generation of more…
Attosecond core-level spectroscopy reveals real-time molecular dynamics
Chemical reactions are complex mechanisms. Many different dynamical processes are involved, affecting both the electrons and the nucleus of the present atoms. Very often the strongly coupled electron and nuclear…
Free-forming organelles help plants adapt to climate change
Scientists uncover how plants “see” shades of light, temperature. Plants’ ability to sense light and temperature, and their ability to adapt to climate change, hinges on free-forming structures in their…
